Cogent Biosciences, Inc.COGTNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+34.4%
5Y CAGR+29.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+34.4%/yr
vs +36.9%/yr prior
5Y CAGR
+29.6%/yr
Recent acceleration
Acceleration
-2.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$63.58M+46.9%
2024$43.28M+25.9%
2023$34.38M+31.1%
2022$26.21M+33.5%
2021$19.64M+12.7%
2020$17.42M+58.8%
2019$10.97M+47.1%
2018$7.45M+59.3%
2017$4.68M+36.3%
2016$3.43M-